Elizabeth M. Whitley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Elizabeth M. Whitley has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
- Guillermina Lozano
Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
35 shared publications - Xiaoping Su
Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas
35 shared publications - An Xu
Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center, The University of Texas MD Anderson Cancer Center, Houston, Texas
34 shared publications - Carlos Vera Recio
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas
34 shared publications - Dhruv Chachad
Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas
34 shared publications - Dung-Fang Lee
Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
34 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figures from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Supplementary Figures 1-6 with figure legends
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Supplementary Figures 1-6 with figure legends
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Gene annotation performed by HOMER of p53 ChIP peaks from p53R248W osteoblasts
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Gene annotation performed by HOMER of p53 ChIP peaks from p53R248W osteoblasts
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
List of primers used in genotyping and qRT-PCR experiments
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
List of primers used in genotyping and qRT-PCR experiments
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Pulmonary metastasis in p53 mutant mice
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Pulmonary metastasis in p53 mutant mice
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
List of mice belonging to different cohorts
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
List of mice belonging to different cohorts
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Missense mutations in the DNA binding domain of p53 are characterized as structural or contact mutations based on their effect on the conformation of the protein. These mutations show gain-of-function (GOF) activities, such as promoting increased metastatic incidence compared with p53 loss, often mediated by the interaction of mutant p53 with a set of transcription factors. These interactions are largely context specific. To understand the mechanisms by which p53 DNA binding domain mutations drive osteosarcoma progression, we created mouse models, in which either the p53 structural mutant p53R172H or the contact mutant p53R245W are expressed specifically in osteoblasts, yielding osteosarcoma tumor development. Survival significantly decreased and metastatic incidence increased in mice expressing p53 mutants compared with p53-null mice, suggesting GOF. RNA sequencing of primary osteosarcomas revealed vastly different gene expression profiles between tumors expressing the missense mutants and p53-null tumors. Further, p53R172H and p53R245W each regulated unique transcriptomes and pathways through interactions with a distinct repertoire of transcription factors. Validation assays showed that p53R245W, but not p53R172H, interacts with KLF15 to drive migration and invasion in osteosarcoma cell lines and promotes metastasis in allogeneic transplantation models. In addition, analyses of p53R248W chromatin immunoprecipitation peaks showed enrichment of KLF15 motifs in human osteoblasts. Taken together, these data identify unique mechanisms of action of the structural and contact mutants of p53.Significance:The p53 DNA binding domain contact mutant p53R245W, but not the structural mutant p53R172H, interacts with KLF15 to drive metastasis in somatic osteosarcoma, providing a potential vulnerability in tumors expressing p53R245W mutation.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants
Missense mutations in the DNA binding domain of p53 are characterized as structural or contact mutations based on their effect on the conformation of the protein. These mutations show gain-of-function (GOF) activities, such as promoting increased metastatic incidence compared with p53 loss, often mediated by the interaction of mutant p53 with a set of transcription factors. These interactions are largely context specific. To understand the mechanisms by which p53 DNA binding domain mutations drive osteosarcoma progression, we created mouse models, in which either the p53 structural mutant p53R172H or the contact mutant p53R245W are expressed specifically in osteoblasts, yielding osteosarcoma tumor development. Survival significantly decreased and metastatic incidence increased in mice expressing p53 mutants compared with p53-null mice, suggesting GOF. RNA sequencing of primary osteosarcomas revealed vastly different gene expression profiles between tumors expressing the missense mutants and p53-null tumors. Further, p53R172H and p53R245W each regulated unique transcriptomes and pathways through interactions with a distinct repertoire of transcription factors. Validation assays showed that p53R245W, but not p53R172H, interacts with KLF15 to drive migration and invasion in osteosarcoma cell lines and promotes metastasis in allogeneic transplantation models. In addition, analyses of p53R248W chromatin immunoprecipitation peaks showed enrichment of KLF15 motifs in human osteoblasts. Taken together, these data identify unique mechanisms of action of the structural and contact mutants of p53.Significance:The p53 DNA binding domain contact mutant p53R245W, but not the structural mutant p53R172H, interacts with KLF15 to drive metastasis in somatic osteosarcoma, providing a potential vulnerability in tumors expressing p53R245W mutation.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figures from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Supplementary Figures 1-6 with figure legends
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Supplementary Figures 1-6 with figure legends
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Unique transcriptional profiles underlie osteosarcomagenesis driven by different p53 mutants
Gene annotation performed by HOMER of p53 ChIP peaks from WT p53 osteoblasts